Integra LifeSciences Corp. (NeuroSciences) recalls MediHoney Gel with Active Leptospermum Honey. Model/Catalog Numbers: (1) 31805, (2) 31815. MediHoney Gel dressing with…
- Recall date
- January 16, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1363-2026
- FDA classification
- Class II
- Brand / firm
- Integra LifeSciences Corp. (NeuroSciences)
- Sold / distributed
- Worldwide - US Nationwide distribution in the states of TX, MI, FL, IN, MO, CA, VA, NJ, PA, SC, TN, RI, NY and the countries of Australia, Austria, Bahrain, Canada, Finland, France, Germany, Greece, Guam, Guernsey, Hungary, Iran (Islamic Republic of), Iraq, Ireland, Israel, Italy, Korea (the Republ…
Why it was recalled
Potential packaging failures, which could lead to a breach in the sterile barrier.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
MediHoney Gel with Active Leptospermum Honey. Model/Catalog Numbers: (1) 31805, (2) 31815. MediHoney Gel dressing with Active Leptospermum Honey provides a moist environment conducive to wound healing and is indicated for light to moderately exuding wounds.
Get recall alerts
Free email alert whenever Integra LifeSciences Corp. (NeuroSciences) has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Integra LifeSciences Corp. (NeuroSciences)